In March 2023, the foundation supported a pharmacological research project entitled “Association of CYP219 Polymorphisms with Escitalopram Metabolism and Intolerance in Filipinos”. The proponent, Ms. Liliana Mae Mora of the University of the Philippines Department of Pharmacology, received a research grant for her paper that could later lead to useful clinical applications in the future.